The DOI matches its Crossref record; 615 of the 615 references it cites were found in a registry or an index.
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology
Open accessAbstract
The first matrix metalloproteinase (MMP) was discovered in 1962 from the tail of a tadpole by its ability to degrade collagen. As their name suggests, matrix metalloproteinases are proteases capable of remodeling the extracellular matrix. More recently, MMPs have been demonstrated to play numerous additional biologic roles in cell signaling, immune regulation, and transcriptional control, all of which are unrelated to the degradation of the extracellular matrix. In this review, we will present milestones and major discoveries of MMP research, including various clinical trials for the use of MMP inhibitors. We will discuss the reasons behind the failures of most MMP inhibitors for the treatment of cancer and inflammatory diseases. There are still misconceptions about the pathophysiological roles of MMPs and the best strategies to inhibit their detrimental functions. This review aims to discuss MMPs in preclinical models and human pathologies. We will discuss new biochemical tools to track their proteolytic activity in vivo and ex vivo, in addition to future pharmacological alternatives to inhibit their detrimental functions in diseases. SIGNIFICANCE STATEMENT: Matrix metalloproteinases (MMPs) have been implicated in most inflammatory, autoimmune, cancers, and pathogen-mediated diseases. Initially overlooked, MMP contributions can be both beneficial and detrimental in disease progression and resolution. Thousands of MMP substrates have been suggested, and a few hundred have been validated. After more than 60 years of MMP research, there remain intriguing enigmas to solve regarding their biological functions in diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–615 of 615
Dufour, A., & Overall, C. M. (2015) · Wiley eBooks · doi:10.1002/9781118772287.ch8 · Cited by 13
Self-citationDegradomics of matrix metalloproteinases in inflammatory diseases
Dufour, A. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/430 · Cited by 13
Self-citationMohan, V., Gaffney, J. P., Solomonov, I., Levin, M., Klepfish, M., Akbareian, S. E., Grünwald, B. T., Dym, O., Eisenstein, M., Yu, K. H., et al. (2021) · Cancers · doi:10.3390/cancers13071679 · Cited by 13
Unravelling the Network of Nuclear Matrix Metalloproteinases for Targeted Drug Design
Frolova, A. S., Petushkova, A. I., Makarov, V. A., Soond, S. M., & Zamyatnin, A. A. (2020) · Biology · doi:10.3390/biology9120480 · Cited by 12
Ahrens, C. C., Chiswick, E. L., Ravindra, K. C., Miller, M. A., Ramseier, J. Y., Isaacson, K., Lauffenburger, D. A., & Griffith, L. G. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00584 · Cited by 11
Paladini, R. D., Wei, G., Kundu, A., Zhao, Q., Bookbinder, L. H., Keller, G. A., Shepard, H. M., & Frost, G. I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364729 · Cited by 8
ProMMP-2: TIMP-1 Complexes Identified in Plasma of Healthy Individuals
Zucker, S., Schmidt, C. E., Dufour, A., Kaplan, R. C., Park, H. I., & Jiang, W. (2009) · Connective Tissue Research · doi:10.1080/03008200802626970 · Cited by 8
Self-citationMahasenan, K. V., Bastian, M., Gao, M., Frost, E., Ding, D., Zorina-Lichtenwalter, K., Jacobs, J., Suckow, M. A., Schroeder, V. A., Wolter, W. R., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00130 · Cited by 8
Jayawardena, D. P., Kulkarni, N. P., & Gill, S. E. (2019) · Metalloproteinases In Medicine · doi:10.2147/mnm.s156245 · Cited by 8
Self-citationRole for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Tokmina‐Roszyk, M., & Fields, G. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003266 · Cited by 6
Tang, W., Zhao, Z., Lian, Z., & Liang, G. (2018) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2018.2473 · Cited by 6
Hohn, M. J., Chang, M., Meisel, J. E., Frost, E., Schwegmann, K., Hermann, S., Schäfers, M. A., Riemann, B., Haufe, G., Breyholz, H., et al. (2018) · ChemistrySelect · doi:10.1002/slct.201803093 · Cited by 4
Martignetti, J. A., Mosig, R., Schulz, R., Kassiri, Z., & Schaffler, M. B. (2014) · Advances in Genomics and Genetics · doi:10.2147/agg.s69675 · Cited by 3
Pathogenesis in Rheumatoid Arthritis: Cytokines
Hueber, A. J., & McInnes, I. B. (2009) · Elsevier eBooks · doi:10.1016/b978-032305475-1.50029-x · Cited by 2
Cited by
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Savin, I. A., Zenkova, M. A., & Sen’kova, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314959 · Cited by 279
Shi, X., Wang, X., Yao, W., Shi, D., Shao, X., Lu, Z., Chai, Y., Song, J., Tang, W., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01885-2 · Cited by 258
The Anti-Photoaging Activity of Peptides from Pinctada martensii Meat
Wei, M., Qiu, H., Zhou, J., Yang, C., Chen, Y., & You, L. (2022) · Marine Drugs · doi:10.3390/md20120770 · Cited by 33
Targeting tumor extracellular matrix with nanoparticles to circumvent therapeutic resistance
Ding, X., Liang, Y., Zhou, S., Wu, Y., Sałata, P., Mikolajczk-Martinez, A., Khosrawipour, V., & Zhang, Z. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113786 · Cited by 20
Metadata
- Authors
- de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 74
- Issue
- 3
- Pages
- 714-770
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W4283331795
- Cited by
- 535
- References
- 615
- FWCI
- 34.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.